Cystic Leukoencephalopathy due to NDUFV1 mutation—A Report of the Phenotype and Its Rare Co-occurrence with Primary Hyperoxaluria

Abstract

The diagnosis of pediatric metabolic disease is complicated and markers of dysfunction are often key in directing appropriate genetic testing. We present a 4-year-old girl with developmental regression following an episode of chicken pox at 7 months. She lost her ability to sit, roll over, or babble. Investigations revealed high plasma lactate at 3.7 mmol/L (normal: < 2 mmol/L). Magnetic resonance imaging of brain at 12 months showed cystic leukoencephalopathy with sparing of basal ganglia, brain stem, and cerebellum. At 16 months, she made developmental progress, spoke a few single words, and was standing with support. Repeat neuroimaging showed the white matter to be more atrophic with well-delineated cysts in the parietal white matter. The clinicoimaging pattern was suspicious of a mitochondrial disorder and a previously reported pathogenic NDUFV1 mutation, predicted to result in mitochondrial complex I deficiency, and was subsequently confirmed by molecular genetic analysis. Coincidentally, she had raised oxalate and glycolate on repeated urine examination with raised urine oxalate: creatinine ratio. Genetic testing confirmed a pathological mutation in AGXT, consistent with primary hyperoxaluria type 1. NDUFV1 mutations result in variable phenotypes including Leigh syndrome, infantile lactic acidosis, cardiomyopathy, leukoencephalopathy, and the majority are described to be progressive and rapidly fatal in some cases. After the initial episode and now aged 4 years, our index case continues to make developmental progress without further episodes of regression, although speech and language delay persists. This case helps broaden our understanding of genotype–phenotype correlations associated with recessively inherited NDUFV1 mutations and highlights that they can be associated with less severe phenotypes. Moreover, there may be coexisting conditions, particularly in consanguineous pedigrees, which careful analysis of their clinical and biochemical data may allude to.

Keywords

NDUFV1 - mitochondrial complex I deficiency - leukoencephalopathy - primary hyperoxaluria

• References

• 1 Varghese F, Atcheson E, Bridges HR, Hirst J. Characterization of clinically identified mutations in NDUFV1, the flavin-binding subunit of respiratory complex I, using a yeast model system. Hum Mol Genet 2015; 24 (22) 6350-6360
• 2 Fassone E, Rahman S. Complex I deficiency: clinical features, biochemistry and molecular genetics. J Med Genet 2012; 49 (9) 578-590
• 3 Angebault C, Charif M, Guegen N , et al. Mutation in NDUFA13/GRIM19 leads to early onset hypotonia, dyskinesia and sensorial deficiencies, and mitochondrial complex I instability. Hum Mol Genet 2015; 24 (14) 3948-3955
• 4 van Rahden VA, Fernandez-Vizarra E, Alawi M , et al. Mutations in NDUFB11, encoding a complex I component of the mitochondrial respiratory chain, cause microphthalmia with linear skin defects syndrome. Am J Hum Genet 2015; 96 (4) 640-650
• 5 Björkman K, Sofou K, Darin N , et al. Broad phenotypic variability in patients with complex I deficiency due to mutations in NDUFS1 and NDUFV1. Mitochondrion 2015; 21: 33-40
• 6 Koene S, Rodenburg RJ, van der Knaap MS , et al. Natural disease course and genotype-phenotype correlations in Complex I deficiency caused by nuclear gene defects: what we learned from 130 cases. J Inherit Metab Dis 2012; 35 (5) 737-747
• 7 Emma F, Bertini E, Salviati L, Montini G. Renal involvement in mitochondrial cytopathies. Pediatr Nephrol 2012; 27 (4) 539-550
• 8 Sofou K, Steneryd K, Wiklund LM, Tulinius M, Darin N. MRI of the brain in childhood-onset mitochondrial disorders with central nervous system involvement. Mitochondrion 2013; 13 (4) 364-371
• 9 Schuelke M, Smeitink J, Mariman E , et al. Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat Genet 1999; 21 (3) 260-261
• 10 Loeffen JL, Smeitink JA, Trijbels JM , et al. Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat 2000; 15 (2) 123-134
• 11 Bugiani M, Invernizzi F, Alberio S , et al. Clinical and molecular findings in children with complex I deficiency. Biochim Biophys Acta 2004; 1659 (2–3) 136-147
• 12 Zafeiriou DI, Rodenburg RJ, Scheffer H , et al. MR spectroscopy and serial magnetic resonance imaging in a patient with mitochondrial cystic leukoencephalopathy due to complex I deficiency and NDUFV1 mutations and mild clinical course. Neuropediatrics 2008; 39 (3) 172-175
• 13 Breningstall GN, Shoffner J, Patterson RJ. Siblings with leukoencephalopathy. Semin Pediatr Neurol 2008; 15 (4) 212-215
• 14 Marin SE, Mesterman R, Robinson B, Rodenburg RJ, Smeitink J, Tarnopolsky MA. Leigh syndrome associated with mitochondrial complex I deficiency due to novel mutations In NDUFV1 and NDUFS2. Gene 2013; 516 (1) 162-167
• 15 von Schnakenburg C, Rumsby G. Identification of new mutations in primary hyperoxaluria type 1 (PH1). J Nephrol 1998; 11 (Suppl. 01) 15-17
• 16 Bénit P, Chretien D, Kadhom N , et al. Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. Am J Hum Genet 2001; 68 (6) 1344-1352
• 17 Laugel V, This-Bernd V, Cormier-Daire V, Speeg-Schatz C, de Saint-Martin A, Fischbach M. Early-onset ophthalmoplegia in Leigh-like syndrome due to NDUFV1 mutations. Pediatr Neurol 2007; 36 (1) 54-57
• 18 Calvo SE, Tucker EJ, Compton AG , et al. High-throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency. Nat Genet 2010; 42 (10) 851-858
• 19 Morán M, Rivera H, Sánchez-Aragó M , et al. Mitochondrial bioenergetics and dynamics interplay in complex I-deficient fibroblasts. Biochim Biophys Acta 2010; 1802 (5) 443-453
• 20 Vilain C, Rens C, Aeby A , et al. A novel NDUFV1 gene mutation in complex I deficiency in consanguineous siblings with brainstem lesions and Leigh syndrome. Clin Genet 2012; 82 (3) 264-270
• 21 Dinwiddie DL, Smith LD, Miller NA , et al. Diagnosis of mitochondrial disorders by concomitant next-generation sequencing of the exome and mitochondrial genome. Genomics 2013; 102 (3) 148-156
• 22 Ortega-Recalde O, Fonseca DJ, Patiño LC , et al. A novel familial case of diffuse leukodystrophy related to NDUFV1 compound heterozygous mutations. Mitochondrion 2013; 13 (6) 749-754
• 23 Lal D, Becker K, Motameny S , et al. Homozygous missense mutation of NDUFV1 as the cause of infantile bilateral striatal necrosis. Neurogenetics 2013; 14 (1) 85-87
• 24 Lieber DS, Calvo SE, Shanahan K , et al. Targeted exome sequencing of suspected mitochondrial disorders. Neurology 2013; 80 (19) 1762-1770
• 25 Sekul E, Strickland S, Flannery D, Figueroa R, Vanderver A. Episodic leukoencephalopathy due to novel mitochondrial complex I NDUFV1 gene mutations. Neurology 2012; 78: 2
• 26 Cochat P, Rumsby G. Primary hyperoxaluria. N Engl J Med 2013; 369 (7) 649-658
• 27 Hoppe B. An update on primary hyperoxaluria. Nat Rev Nephrol 2012; 8 (8) 467-475
• 28 Coulter-Mackie MB, White CT, Lange D, Chew BH. Primary hyperoxaluria type 1. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, et al, eds. Gene Reviews(R). Seattle, Washington: University of Washington; 1993